Your browser doesn't support javascript.
loading
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles.
Cejas, Paloma; Li, Lewyn; O'Neill, Nicholas K; Duarte, Melissa; Rao, Prakash; Bowden, Michaela; Zhou, Chensheng W; Mendiola, Marta; Burgos, Emilio; Feliu, Jaime; Moreno-Rubio, Juan; Guadalajara, Héctor; Moreno, Víctor; García-Olmo, Damián; Bellmunt, Joaquim; Mullane, Stephanie; Hirsch, Michelle; Sweeney, Christopher J; Richardson, Andrea; Liu, X Shirley; Brown, Myles; Shivdasani, Ramesh A; Long, Henry W.
Affiliation
  • Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Li L; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • O'Neill NK; Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Duarte M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Rao P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Bowden M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Zhou CW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Mendiola M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Burgos E; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Feliu J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Moreno-Rubio J; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Guadalajara H; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Moreno V; Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • García-Olmo D; Department of Pathology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Bellmunt J; Department of Pathology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Mullane S; Department of Medical Oncology, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
  • Hirsch M; Precision Oncology Laboratory, Infanta Sofia University Hospital, Madrid, Spain.
  • Sweeney CJ; Department of Surgery, Jimenez Diaz Foundation, Madrid, Spain.
  • Richardson A; Clinical Research Unit, Jimenez Diaz Foundation, Madrid, Spain.
  • Liu XS; Department of Surgery, Jimenez Diaz Foundation, Madrid, Spain.
  • Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Shivdasani RA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
  • Long HW; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Nat Med ; 22(6): 685-91, 2016 06.
Article in En | MEDLINE | ID: mdl-27111282
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Enhancer Elements, Genetic / Histone Code / Neoplasms Limits: Animals / Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2016 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / Enhancer Elements, Genetic / Histone Code / Neoplasms Limits: Animals / Humans Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2016 Type: Article Affiliation country: United States